CDMO News
Piramal Pharma to Invest $90M to Expand US Manufacturing Facilities
Piramal Pharma Limited has announced a $90 million investment to expand two of its manufacturing sites in the United States, aligning with growing demand for domestic drug production and the trend toward onshoring pharmaceutical supply chains. The investment was revealed in
13 May 2025
Stay ahead of trends and best practices
